RICHMAP
RICHMAP · Stock · NASDAQ NMS - GLOBAL MARKET ← Markets

AMGN · NASDAQ NMS - GLOBAL MARKET

Amgen Inc

Biotechnology
$347.37
▲ 2.65 (0.77%)
Finnhub · 26. 6. 24. 오전 4:05 기준 (실시간~15분 지연)
차트 TradingView

재무 요약

Finnhub /stock/metric · 연간 기준 · 캐시 6h
PER (연간)
23.63
EPS (연간)
14.23
매출/주 (연간)
67.81
총이익률 (연간)
70.78%
영업이익률 (연간)
25.43%
순이익률 (연간)
데이터 없음
ROE
89.06%
배당수익률
2.92%
52주 최고
391.29
52주 최저
267.83
시총 (M)
186,048 USDM
상장 주식수 (M)
539.71

▸ Finnhub /stock/profile2 · 캐시 24h · 모든 수치 API 원값 (RICHMAP 가공·추정 없음)

관련 뉴스

Finnhub /company-news · 최근 14일 · 캐시 30min
Yahoo · 2026. 6. 23.

Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?

AMGN's biosimilars business is driving growth, with new launches and a deep pipeline helping offset patent losses in key branded drugs.

원문 보기 ↗ Yahoo
SeekingAlpha · 2026. 6. 23.

Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)

Viatris Inc. hits a 52-week high, driven by a strong late-stage pipeline, but shares corrected on Effexor sales decline. Click for this VTRS update.

원문 보기 ↗ SeekingAlpha
Yahoo · 2026. 6. 23.

2 Underrated Weight Loss Stocks to Buy and Hold

They look well-positioned to grab a slice of the fast-growing anti-obesity market.

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

Willful Patent Infringement Verdict Might Change The Case For Investing In Amgen (AMGN)

In June 2026, a Delaware jury ruled that Amgen and its subsidiary Teneobio willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704 in damages with the option to seek a tri…

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court

Yahoo Finance Senior Reporter Brooke DiPalma joins Josh Lipton in highlighting the day's biggest stories and stock moves, including AbbVie's (ABBV) $10.9 billion acquisition of Apogee Therapeutics (AP…

원문 보기 ↗ Yahoo
ChartMill · 2026. 6. 23.

Which dow jones stocks are moving on Monday?

Join us in exploring the top gainers and losers within the dow jones index one hour before the close of the markets on Monday as we examine the latest happenings in today's session.

원문 보기 ↗ ChartMill
Yahoo · 2026. 6. 23.

Stock Market Today: Dow Up, Big Tech Falls Amid Rate Hike Forecasts; These AI Stocks Test Entries (Live Coverage)

The Dow Jones index rises as Treasury Secretary Scott Bessent makes an Iran move. SpaceX skids but some AI stocks test buy points.

원문 보기 ↗ Yahoo
ChartMill · 2026. 6. 23.

Top dow jones movers in Monday's session

Uncover the latest developments among dow jones stocks in today's session. Stay tuned to the dow jones index's top gainers and losers on Monday.

원문 보기 ↗ ChartMill
Yahoo · 2026. 6. 23.

Stock Market Today: Dow Up As Bessent Makes Iran Move; Microsoft Falls After Nadella Says This (Live Coverage)

The Dow Jones index rises as Treasury Secretary Scott Bessent makes an Iran move. Microsoft falls on the stock market today. SpaceX skids.

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 22.

Dow Jones opens higher but Nasdaq flat as hawkish Fed still looms

9.55am: Dow up but Nasdaq flat US stocks were showing a familiar split in opening trades, with the Dow Jones opening up 0.5% as investors rotate into cyclical and defensive blue chips including JPMorg…

원문 보기 ↗ Yahoo
Benzinga · 2026. 6. 22.

Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and specialty grocers win.

원문 보기 ↗ Benzinga
Yahoo · 2026. 6. 20.

Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?

Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance sheet.

원문 보기 ↗ Yahoo
⚡ WHAT-IF ARENA · SIMULATION · 가상 · 실제 거래 아님

내 성향 트레이더로 도전

주어는 당신의 성향이지 이 종목이 아닙니다. 객관식 3개로 트레이더를 만들고, 6시간 동안 30분마다 가상 매매하는 걸 관전합니다. 하루 1번, 외부 개입 0.

⚠ 정보 제공 목적 · 투자 추천·자문 아님

본 페이지는 정보 제공 목적의 종목 정보 색인이며, 투자 권유·자문·중개가 아닙니다. RICHMAP은 증권사·금융투자업자가 아닙니다. 시세·재무·뉴스는 외부 데이터 소스(Finnhub 등)의 정보로 실시간성·정확성을 보증하지 않습니다. 모든 수치는 API 원값으로 RICHMAP의 가공·추정이 없으며, 조회 실패 시 "데이터 없음"으로 명시됩니다. 투자 판단과 그 결과 책임은 본인에게 있으며, 실제 거래는 정식 인가 증권사를 통해 본인 판단하에 진행하시기 바랍니다.